Table 1.

Main patient characteristics.

ID	Age [years]	cTNM1	Surgery2	Histological type3	ER, PgR, MIB-14	ypTNM5	PET/CT scanner6
1	60	T2 N1	TM+ALND	IDC	ER 0%	T0 N0	D LS
					PgR 0%
					MIB-1 40%
2	73	T2 N0	QUAD+SND	IDC	ER 95%	T1c N0	B mCT
					PgR 90%
					MIB-1 10%
3	58	T2 N0	TM+SND	IDC	ER 0%	T0 N0	B mCT
					PgR 0%
					MIB-1 25%
4	71	T2 N0	TM+ALND	IDC	ER 95%	T1b N0	D LS
					PgR 18%
					MIB-1 18%
5	53	T2 N1	TM+ALND	IDC	ER 90%	T1b N1mic	D LS
					PgR 5%
					MIB-1 45%
6	61	T2 N0	QUAD+ALND	IDC	ER9 100%	T1 N1	B mCT
					PgR 5%
					MIB-1 5%
7	53	T4 N1	TM+ALND	IDC	ER 100%	T0 N3a	D LS
					PgR 100%
					MIB-1 35%
8	31	T2 N1	TM+ALND	IDC	ER 80%	T1a N0	D LS
					PgR 15%
					MIB-1 35%
9	59	T4d N3a	TM+ALND	IDC	ER 0%	T4dN0	D LS
					PgR 0%
					MIB-1 40%
10	61	T2 N0	TM+SND	IDC	ER 95%	T0 N0	D LS
					PgR 2%
					MIB-1 15%
11	44	T1c N1	QUAD+ALND	IDC	ER3 0%	T1a N0	D LS
					PgR 0%
					MIB-1 5%
12	44	T4b N0	TM+ALND	IDC	ER 0%	T0 N0	B mCT
					PgR 0%
					MIB-1 25%
13	55	T2 N1	QUAD+ALND	IDC	ER 0%	T0 N0	B mCT
					PgR 0%
					MIB-1 40%
14.	47	T1c N1	QUAD+SND	IDC	ER 95%	Tis N0	D LS
					PgR 0%
					MIB-1 35%
15	54	T2 N0	QUAD+SND	IDC	ER 60%	T0 N0	D LS
					PgR 3%
					MIB-1 23%

¹cTNM, cytological TNM classification.

²QUAD, quadrantectomy; ALND, axillary lymph node dissection; SND, sentinel node dissection; TM, total mastectomy.

³IDC, Invasive ductal carcinoma.

⁴ER, estrogen receptor; PgR, progesterone receptor; MIB-1, proliferation index.

⁵ypTNM, post-therapy pathological TNM classification.

⁶D LS, Discovery LS PET/CT scanner; B mCT, Biograph 20 mCT PET/CT scanner.